Top 20 global biopharma companies report 9.6 per cent market cap growth in Q1 2024: GlobalData
it went from $3.67 trillion as on 31 December 2023 to $4 trillion as on 31 March 2024
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Market Capitalisation
Top 20 global biopharma companies report 1.6 per cent per cent market cap growth to $3.67 tn in…
Four companies – Lilly (59.2 per cent), Novo Nordisk (51.5 per cent), Vertex Pharmaceuticals (41.4 per cent) and Regeneron…
Top 20 global biopharma companies report 2.3 per cent market cap growth in Q2 2023: GlobalData
Market cap surged from $3.49 trillion during the first quarter (Q1) of 2023 to $3.56 trillion in Q2 2023
Top 20 global pharma companies by MCap saw 10.2 per cent rise in MCap in Q2 2020: GlobalData
Johnson & Johnson maintained its top position with MCap growth of 7.2 per cent on a QoQ basis
Small market cap companies more dependent on COVID-19 pipeline drug: GlobalData
The small-cap bio/pharma companies without a COVID-19 drug, on average, declined by 19.4 per cent